These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

261 related items for PubMed ID: 27323655

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2. [Glomerulonephritis with IgA mesangial deposits].
    Pillebout E, Nochy D.
    Nephrol Ther; 2010 Nov; 6(6):545-57. PubMed ID: 20399170
    [Abstract] [Full Text] [Related]

  • 3. Treatment of IgA nephropathy: Recent advances and prospects.
    Coppo R.
    Nephrol Ther; 2018 Apr; 14 Suppl 1():S13-S21. PubMed ID: 29606258
    [Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5. Points of view in nephrology: personalized management of IgA nephropathy, beyond KDIGO.
    Trimarchi H, Fervenza FC, Coppo R.
    J Nephrol; 2024 Apr; 37(3):739-745. PubMed ID: 38236471
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [Management of IgA nephropathy].
    Amoroso L, De Sanctis L, Cappelli P, Di Vito R, Sirolli V, Bonomini M.
    G Ital Nefrol; 2011 Apr; 28(6):622-32. PubMed ID: 22167613
    [Abstract] [Full Text] [Related]

  • 8. Clinical usefulness of the Oxford classification in determining immunosuppressive treatment in IgA nephropathy.
    Yoon CY, Chang TI, Kang EW, Lim BJ, Kie JH, Kee YK, Kim H, Park S, Yun HR, Jung SY, Jhee JH, Kwon YE, Oh HJ, Park JT, Yoo TH, Kang SW, Jeong HJ, Han SH.
    Ann Med; 2017 May; 49(3):217-229. PubMed ID: 27764976
    [Abstract] [Full Text] [Related]

  • 9. Therapeutic approach of patients with IgA nephropathy.
    Goumenos DS, Brown CB.
    Ren Fail; 2004 Mar; 26(2):171-7. PubMed ID: 15287202
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. IgA Nephropathy in Elderly Patients.
    Sevillano AM, Diaz M, Caravaca-Fontán F, Barrios C, Bernis C, Cabrera J, Calviño J, Castillo L, Cobelo C, Delgado-Mallén P, Espinosa M, Fernandez-Juarez G, Fernandez-Reyes MJ, Garcia-Osuna R, Garcia P, Goicoechea M, Gonzalez-Cabrera F, Guzmán DA, Heras M, Martín-Reyes G, Martinez A, Olea T, Peña JK, Quintana LF, Rabasco C, López Revuelta K, Rodas L, Rodriguez-Mendiola N, Rodriguez E, San Miguel L, Sanchez de la Nieta MD, Shabaka A, Sierra M, Valera A, Velo M, Verde E, Ballarin J, Noboa O, Moreno JA, Gutiérrez E, Praga M, Spanish Group for the Study of Glomerular Diseases (GLOSEN).
    Clin J Am Soc Nephrol; 2019 Aug 07; 14(8):1183-1192. PubMed ID: 31311818
    [Abstract] [Full Text] [Related]

  • 15. Treatment of IgA nephropathy.
    Barratt J, Feehally J.
    Kidney Int; 2006 Jun 07; 69(11):1934-8. PubMed ID: 16641928
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. [Considerations on the treatment of IgA nephropathy on the basis of the results of the latest studies (STOP-IgAN, TESTING, NEFIGAN)].
    Nagy J, Sági B, Máté J, Vas T, Kovács T.
    Orv Hetil; 2017 Dec 07; 158(49):1946-1952. PubMed ID: 29199436
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. [Immunoglobulin A nephropaty: clinical practice guidelines].
    Fayad A, Robaina Sindin J, Calvo Abeucci M, Trimarchi H, Vázquez V.
    Medicina (B Aires); 2011 Dec 07; 71 Suppl 2():1-26. PubMed ID: 21903506
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.